Our study demonstrated that inhibition of NLRP3 inflammasome activity by DIO alleviated renal inflammation and scarring in DN rats, evidenced by suppressed caspase-1 activation, reduced IL-1β levels, and diminished expression of fibrotic markers (fibronectin and collagen IV). The gene discussed is NLRP3; the disease is liver dysplastic nodule.